Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011

by Forero Ivan, Okada Hideho, Topalian Suzanne L, Gajewski Thomas F, Korman Alan J, Melero Ignacio
Published 2012-05-01

Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma

by Fujita Mitsugu, Zhu Xinmei, Low Keri L, Ueda Ryo, Sasaki Kotaro, Whiteside Theresa L, Butterfield Lisa H, Okada Hideho
Published 2007-12-01

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

by Hatano Manabu, Kuwashima Naruo, Tatsumi Tomohide, Dusak Jill E, Nishimura Fumihiko, Reilly Karlyne M, Storkus Walter J, Okada Hideho
Published 2004-11-01

Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

by Eguchi Junichi, Dusak Jill E, Fujita Mitsugu, Sasaki Kotaro, Nishimura Fumihiko, Zhu Xinmei, Fellows-Mayle Wendy, Storkus Walter J, Walker Paul R, Salazar Andres M, Okada Hideho
Published 2007-02-01

miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy

by Martinson Jeremy, Reinhart Todd A, McDonald Heather A, Ueda Ryo, Hoji Aki, Kohanbash Gary, Sasaki Kotaro, Lotze Michael T, Marincola Francesco M, Wang Ena, Fujita Mitsugu, Okada Hideho
Published 2010-02-01

Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

by Torres-Trejo Alejandro, Hamilton Ronald L, Bejjani Ghassan K, Kondziolka Douglas S, Lunsford L Dade, Walter Kevin A, Lieberman Frank S, Okada Hideho, Kalinski Pawel, Cai Quan, Mabold Jennifer L, Edington Howard D, Butterfield Lisa H, Whiteside Theresa L, Potter Douglas M, Schold S Clifford, Pollack Ian F
Published 2007-12-01